Schöpf–Schulz–Passarge syndrome
| Schöpf–Schulz–Passarge syndrome | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Dermatology, Genetics |
| Symptoms | Eyelid cysts, Palmoplantar keratoderma, Hypodontia, Hypotrichosis |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Symptomatic management |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | N/A |
| Deaths | N/A |
Schöpf–Schulz–Passarge syndrome (SSPS) is a rare genetic disorder characterized by a combination of ectodermal dysplasia features, including eyelid cysts, palmoplantar keratoderma, hypodontia, and hypotrichosis. It is named after the German dermatologists who first described the condition.
Clinical Features[edit]
The hallmark features of Schöpf–Schulz–Passarge syndrome include:
- Eyelid cysts: Patients typically develop multiple apocrine hidrocystomas on the eyelids, which are benign cystic lesions.
- Palmoplantar keratoderma: Thickening of the skin on the palms and soles is common, often presenting in childhood.
- Hypodontia: A reduced number of teeth, particularly the absence of permanent teeth, is frequently observed.
- Hypotrichosis: Sparse hair growth, particularly on the scalp, is another characteristic feature.
Additional features may include nail dystrophy, syringofibroadenoma of the skin, and an increased risk of skin cancer.
Genetics[edit]
Schöpf–Schulz–Passarge syndrome is inherited in an autosomal recessive manner. It is associated with mutations in the WNT10A gene, which plays a crucial role in the development of ectodermal structures. Genetic testing can confirm the diagnosis by identifying mutations in this gene.
Diagnosis[edit]
Diagnosis of SSPS is primarily clinical, based on the characteristic features. Genetic testing can provide confirmation. A thorough family history and examination of the skin, teeth, and hair are essential components of the diagnostic process.
Management[edit]
There is no cure for Schöpf–Schulz–Passarge syndrome, and treatment is symptomatic. Management strategies may include:
- Surgical removal of eyelid cysts if they cause discomfort or vision problems.
- Use of emollients and keratolytics for palmoplantar keratoderma.
- Dental care to address hypodontia, including the use of dental prosthetics.
- Regular dermatological evaluations to monitor for skin cancer.
Prognosis[edit]
The prognosis for individuals with Schöpf–Schulz–Passarge syndrome varies. While the condition is lifelong, many symptoms can be managed effectively with appropriate care. Regular monitoring for complications, particularly skin cancer, is important.
Also see[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian